関連する実験動画
Updated: Sep 8, 2025

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.0K
口服用リチェン・プランスの薬剤療法とコルチコステロイドの組み合わせ: 系統的レビュー
W Y Kot1, X X Deng2, L W Zheng3
1Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
JDR clinical and translational research
|September 6, 2025
まとめ
薬草とコルチコステロイドを併用することで,口腔リケーン・プランス (OLP) の優れた治療が可能になります. このアプローチはOLPの症状と再発を効果的に軽減し,有望な代替治療法を提供します.
科学分野:
- 統合医療
- 口腔病理学
- 薬理学について
背景:
- オーラル・リチェン・プランス (OLP) は慢性的で前発性疾患であり,効果的な管理戦略が必要である.
- 現在のOLP治療には限界があり 代替治療方法の必要性を強調しています
- 薬草とコルチコステロイドの組み合わせは,OLPの潜在的相乗効果のある治療法です.
研究 の 目的:
- 経口リケーン・プランス (OLP) の管理におけるハーブ医薬品とコルチコステロイドの組み合わせの有効性を体系的に検討する.
- この併用治療の薬効性と治療の可能性を分析する.
- 統合 OLP 治療の有効性に関する知識の不足を解決する.
主な方法:
- 主要なデータベース (PubMed, Web of Science, Scopus, Cochrane Library, CNKI, WanFang) で体系的な文献検索が行われました.
- ランダム化比較試験は,中国特許薬 (CPM) とコルチコステロイドと,コルチコステロイド単独のOLPを比較したものです.
- データ抽出は,症状緩和と薬効性を含む研究特性と介入,治療結果に焦点を当てた.
主要な成果:
- 1164人の参加者を含む19件のランダム化対照試験を分析した.
- 中国製の特許医薬品 (CPM) は11種類で,有効性が向上し,OLPの再発率が低下し,合併症が少なくなった.
- コルチコステロイド単独投与と比較して,併用療法により,灼熱感,病変の大きさおよび重度が著しく低下し,治療の全体的な効果が向上しました.
結論:
- 薬草とコルチコステロイドの組み合わせは,口腔リケーンプランス (OLP) の管理において優れた有効性を示しています.
- 有効な化学成分を特定し,薬草の作用メカニズムを明らかにするために,さらなる研究が不可欠です.
- CPMの組成と治療効果の高度な科学的検証は,OLPの治療戦略を最適化するために不可欠です.
関連する概念動画
Inflammatory Bowel Disease IV: Pharmacological Management
177
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
177
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
382
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
382
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
200
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
200
Antiasthma Drugs: Leukotriene Modifiers
453
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
453
COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264

